Abstract P5-12-03: Initial report of a randomized trial of letrozole in high risk women taking hormone replacement therapy
Carol J. Fabian(Washington Hospital), Michael Alvarado(University of California, San Francisco), Trina Metheny(University of Kansas), Hung‐Wen Yeh(Children's Mercy Hospital), Carola M. Zalles(Mercy Hospital), Jennifer L. Nydegger(University of Kansas Medical Center), Brian K. Petroff(University of Kansas), Bruce F. Kimler(The University of Kansas Cancer Center)
Cited by 0
Related Papers
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
|Nature Medicine|2018|1k
American Society of Clinical Oncology Position Statement on Obesity and Cancer
|Journal of Clinical Oncology|2014|524
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
|PubMed|2002|383
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
|Breast Cancer Research|2009|298